Moderna To Present Respiratory & Cytomegalovirus Research at the ESCMID Global Congress
CAMBRIDGE, MA / ACCESSWIRE / April 25, 2024 /Moderna, Inc. (NASDAQ:MRNA) today announced that the Company will present data from its respiratory portfolio, including vaccines and vaccine candidates against COVID-19 (mRNA-1273, mRNA-1283), …